James J Loughlin's Net Worth
$9.37 Million
Who is James J Loughlin?
James J Loughlin has an estimated net worth of $9.37 Million. This is based on reported shares across multiple companies, which include ALFACELL CORP, InspireMD, Inc., Edge Therapeutics, Inc., CELGENE CORP /DE/, and DATASCOPE CORP.
SEC CIK
James J Loughlin's CIK is 0001276550
Past Insider Trading and Trends
2015 was James J Loughlin's most active year for acquiring shares with 13 total transactions. James J Loughlin's most active month to acquire stocks was the month of May. 2019 was James J Loughlin's most active year for disposing of shares, totalling 21 transactions. James J Loughlin's most active month to dispose stocks was the month of May. 2018 saw James J Loughlin paying a total of $1,084,192.50 for 84,795 shares, this is the most they've acquired in one year. In 2016 James J Loughlin cashed out on 85,518 shares for a total of $3,356,402.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ALFACELL CORP No price found
InvestorJames J Loughlin owns 10,000 units of Common Stock. In the year 2004 James J Loughlin filed a total of 10 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
| +300.00% | 7.5K |
$2.04 | $15,267.80 | 10K |
Jul 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
|
∞
| 2.5K |
$4.54 | $11,360.00 | 2.5K |
Sep 21 - Sep 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
InspireMD, Inc. (NSPR) Snapshot price: $2.8
InvestorJames J Loughlin owns 51,501 units of Common Stock which is worth $144,202.80. In the year 2012 James J Loughlin filed a total of 12 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +3,331.11% | 50K |
$0.59 | $29,500.00 | 51.5K |
Mar 21
| |||
Form 4
| +0.07% | 1 |
—
|
—
| 1.5K |
Jan 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 9
| |||
Form 4
|
∞
| 15K |
$2.00 | $30,000.00 | 15K |
Apr 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Edge Therapeutics, Inc. (PDSB) Snapshot price: $2.91
InvestorJames J Loughlin owns 26,625 units of Common Stock which is worth $77,478.75. In the year 2015 James J Loughlin filed a total of 10 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 28
| |||
Form 4
| +60.15% | 10K |
—
|
—
| 26.63K |
Mar 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
| +100.00% | 3K |
$9.24 | $27,720.00 | 6K |
Mar 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
∞
| 3K |
$7.63 | $22,901.43 | 3K |
Mar 11
| |||
Form 4
|
∞
| 19.63K |
$10.88 |
—
| 19.63K |
Oct 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CELGENE CORP /DE/ No price found
InvestorJames J Loughlin used to own units in Common Stock but no longer holds any shares there. In the year 2007 James J Loughlin filed a total of 40 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -43.66K |
—
|
—
|
0
|
Nov 20
| |||
Form 4
| +8.35% | 3.23K |
—
|
—
| 41.86K |
Jun 13 - Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
| +3.21% | 1.2K |
$54.88 | -$1,494,078.65 | 38.64K |
Feb 7
| |||
Form 4
| +0.90% | 334 |
—
|
—
| 37.44K |
Jun 17
| |||
Form 4
| +7.98% | 2.74K |
—
|
—
| 37.1K |
Jun 13 - Jun 15
| |||
Form 4
| +41.05% | 10K |
$54.49 | -$568,762.50 | 34.36K |
Jun 4
| |||
Form 4
|
—
|
0
|
$59.60 | -$599,677.50 | 24.36K |
Mar 12
| |||
Form 4
| +3.11% | 734 |
—
|
—
| 24.36K |
Jul 1
| |||
Form 4
|
—
|
0
|
$81.50 | -$1,926,682.50 | 23.63K |
Scheduled
|
Jun 26
| ||
Form 4
| +1.43% | 333 |
—
|
—
| 23.63K |
Jun 17
| |||
Form 4
| +1.64% | 375 |
—
|
—
| 23.29K |
Jun 14 - Jun 15
| |||
Form 4
|
—
|
0
|
$76.48 | -$879,120.00 | 22.92K |
May 1
| |||
Form 4
|
—
|
0
|
$70.23 | -$2,412,900.00 | 22.92K |
Aug 23
| |||
Form 4
| +3.30% | 733 |
—
|
—
| 22.92K |
Jul 1
| |||
Form 4
| +1.52% | 333 |
—
|
—
| 22.19K |
Jun 15 - Jun 17
| |||
Form 4
| +10.45% | 2.07K |
—
|
—
| 21.85K |
Jun 12
| |||
Form 4
| -9.60% | -2.10K |
$104.12 | -$218,652.00 | 19.79K |
Feb 22
| |||
Form 4
| +3.47% | 733 |
—
|
—
| 21.89K |
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
| +24.29% | 4.13K |
—
|
—
| 21.15K |
Jun 12 - Jun 13
| |||
Form 4
|
—
|
0
|
$59.95 | -$1,252,000.00 | 17.02K |
Aug 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
| +32.07% | 2.07K |
—
|
—
| 8.51K |
Jun 12 - Jun 13
| |||
Form 4
| +34.19% | 1.72K |
—
|
—
| 6.74K |
Jun 13 - Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
| +13.56% | 600 |
$60.29 | $36,174.00 | 5.03K |
Jun 22
| |||
Form 4
| +44.84% | 1.37K |
—
|
—
| 4.42K |
Jun 16 - Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
| +81.31% | 1.37K |
—
|
—
| 3.06K |
Jun 15 - Jun 17
| |||
Form 4
| +68.50% | 685 |
—
|
—
| 1.69K |
Jun 16 - Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
| +60.00% | 600 |
$39.57 | $23,742.00 | 1.6K |
May 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
DATASCOPE CORP No price found
InvestorJames J Loughlin owns 1,000 units of Common Stock par value $.01 per share. James J Loughlin used to own units in Common Stock but no longer holds any shares there. In the year 2004 James J Loughlin acquired a total of 1,000 shares in DATASCOPE CORP at a cost of $29,800.00, James also disposed a total of 1,000 shares of DATASCOPE CORP equalling to $53,000.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -1.00K |
$53.00 | -$53,000.00 |
0
|
Jan 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 4
|
∞
| 1K |
$29.80 | $29,800.00 | 1K |
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||